| Breakdown | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 734.76M | 599.30M | 207.65M | 158.33M | 126.01M |
| Gross Profit | 311.33M | 599.30M | 207.65M | 158.33M | 126.01M |
| EBITDA | 265.48M | 940.88M | 0.00 | 0.00 | 0.00 |
| Net Income | 26.26M | 112.09M | 360.39M | 78.90M | 16.61M |
Balance Sheet | |||||
| Total Assets | 3.78B | 3.68B | 4.17B | 2.44B | 3.11B |
| Cash, Cash Equivalents and Short-Term Investments | 224.46M | 191.45M | 125.83M | 141.82M | 35.70M |
| Total Debt | 118.54M | 71.66M | 367.19M | 796.56M | 1.49B |
| Total Liabilities | 877.12M | 878.34M | 1.58B | 796.56M | 1.49B |
| Stockholders Equity | 2.44B | 2.38B | 2.24B | 1.27B | 1.20B |
Cash Flow | |||||
| Free Cash Flow | 237.29M | 520.08M | 149.65M | 794.77M | 226.36M |
| Operating Cash Flow | 291.00M | 764.69M | 151.26M | 796.33M | 226.43M |
| Investing Cash Flow | -355.38M | -567.70M | -266.57M | 76.35M | -139.29M |
| Financing Cash Flow | -75.66M | -149.10M | 90.78M | -762.86M | -306.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$6.34B | ― | 5.13% | 11.28% | -17.62% | -3.54% | |
67 Neutral | HK$395.30M | 5.31 | 3.00% | 4.88% | -7.97% | 53.91% | |
65 Neutral | HK$1.37B | 4.31 | 8.51% | 7.43% | -2.69% | -8.21% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | HK$260.40M | 6.53 | 1.09% | ― | 8.77% | -76.88% | |
44 Neutral | HK$502.23M | -0.18 | -62.54% | ― | -61.09% | -1306.43% | |
42 Neutral | HK$172.10M | -1.47 | -29.10% | ― | -5.72% | -6.26% |